Innovation in the pharmaceutical industry: New estimates of R&D costs von DiMasi, Joseph A., Grabowski, Henry G., Hansen, Ronald W.

Volltext

Economics of New Oncology Drug Development von DiMasi, Joseph A, Grabowski, Henry G

Volltext

The cost of biopharmaceutical R&D: is biotech different? von DiMasi, Joseph A., Grabowski, Henry G.

Volltext

The price of innovation: new estimates of drug development costs von DiMasi, Joseph A, Hansen, Ronald W, Grabowski, Henry G

Volltext

Economic Return of Clinical Trials Performed Under the Pediatric Exclusivity Program von Li, Jennifer S, Eisenstein, Eric L, Grabowski, Henry G, Reid, Elizabeth D, Mangum, Barry, Schulman, Kevin A, Goldsmith, John V, Murphy, M. Dianne, Califf, Robert M, Benjamin, Daniel K

Volltext

The Cost of Drug Development von DiMasi, Joseph A, Grabowski, Henry G, Hansen, Ronald W

Volltext

Generic competition and market exclusivity periods in pharmaceuticals von Grabowski, Henry G., Kyle, Margaret

Volltext

The economic returns of pediatric clinical trials of antihypertensive drugs von Baker-Smith, Carissa M., MD, MS, Benjamin, Daniel K., MD, PhD, Grabowski, Henry G., PhD, Reid, Elizabeth D., BA, Mangum, Barry, PharmD, Goldsmith, John V., PhD, Murphy, M. Dianne, MD, Edwards, Rex, BS, Eisenstein, Eric L., DBA, Sun, Jessica, MD, Califf, Robert M., MD, Li, Jennifer S., MD, MHS

Volltext

Risk-based decision making and ethical considerations in donor compensation for plasma-derived medicinal products von Skinner, Mark W., Hedlund Hoppe, P. Ann, Grabowski, Henry G., Manning, Richard, Tachdjian, Raffi, Crone, James F., Youngner, Stuart J.

Volltext

Cost of innovation in the pharmaceutical industry von DiMasi, Joseph A, Hansen, Ronald W, Grabowski, Henry G, Lasagna, Louis

Volltext

An Economic Analysis of Global Policy Proposals to Prohibit Compensation of Blood Plasma Donors von Grabowski, Henry G., Manning, Richard L.

Volltext

Brand Loyalty, Entry, and Price Competition in Pharmaceuticals after the 1984 Drug Act von Grabowski, Henry G., Vernon, John M.

Volltext

Returns to R&D on new drug introductions in the 1980s von Grabowski, Henry G, Vernon, John M

Volltext

Follow-on biologics: data exclusivity and the balance between innovation and competition von Grabowski, Henry

Volltext

R&D Costs and Returns by Therapeutic Category von DiMasi, Joseph A., Grabowski, Henry G., Vernon, John

Volltext

Entry and competition in generic biologics von Grabowski, Henry G., Ridley, David B., Schulman, Kevin A.

Volltext

Impact of economic, regulatory, and patent policies on innovation in cancer chemoprevention von Grabowski, Henry G, Moe, Jeffrey L

Volltext

Extraordinary claims require extraordinary evidence von DiMasi, Joseph A., Hansen, Ronald W., Grabowski, Henry G.

Volltext

Misleading Congress About Drug Development: Reply von DiMasi, Joseph A., Hansen, Ronald W., Grabowski, Henry G.

Volltext

Setting the record straight on setting the record straight: Response to the Light and Warburton rejoinder von DiMasi, Joseph A., Hansen, Ronald W., Grabowski, Henry G.

Volltext